by Bob Yirka , Medical Xpress Graphical abstract of immunocytokines for the treatment of glioblastoma. A team of researchers from University Hospital Zurich and the University of Zurich, the Swiss Federal Institute of Technology and biotechnology company Philochem, has found fusing cytokines with antibodies to be an effective treatment for glioblastoma in mice. In their paper published...